Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Finton, Sarah [VerfasserIn]   i
 Bolm, Louisa [VerfasserIn]   i
 Nebbia, Martina [VerfasserIn]   i
 Petruch, Natalie [VerfasserIn]   i
 Férnandez-Del Castillo, Carlos [VerfasserIn]   i
 Qadan, Motaz [VerfasserIn]   i
 Lillemoe, Keith D. [VerfasserIn]   i
 Wellner, Ulrich F. [VerfasserIn]   i
 Distler, Marius [VerfasserIn]   i
 Zimmermann, Carolin [VerfasserIn]   i
 Weitz, Jürgen [VerfasserIn]   i
 Rückert, Felix [VerfasserIn]   i
 Rahbari, Nuh Nabi [VerfasserIn]   i
 Reißfelder, Christoph [VerfasserIn]   i
 Nappo, Gennaro [VerfasserIn]   i
 Keck, Tobias [VerfasserIn]   i
 Zerbi, Alessandro [VerfasserIn]   i
 Ferrone, Cristina R. [VerfasserIn]   i
Titel:The role of adjuvant therapy in duodenal adenocarcinoma and intestinal subtype ampullary carcinoma after curative resection
Verf.angabe:Sarah Finton, BS, Louisa Bolm, MD, Martina Nebbia, MD, Natalie Petruch, MD, Carlos Férnandez-Del Castillo, MD, Motaz Qadan, MD, PhD, Keith D. Lillemoe, MD, Ulrich F. Wellner, MD, Marius Distler, MD, Carolin Zimmermann, MD, Jürgen Weitz, MD, Felix Rückert, MD, Nuh N. Rahbari, MD, Christoph Reissfelder, MD, Gennaro Nappo, MD, Tobias Keck, MD, Alessandro Zerbi, MD, and Cristina R. Ferrone, MD
E-Jahr:2024
Jahr:December 2024
Umfang:7 S.
Fussnoten:Gesehen am 08.04.2025
Titel Quelle:Enthalten in: Annals of surgery
Ort Quelle:[Erscheinungsort nicht ermittelbar] : Lippincott Williams & Wilkins, 1885
Jahr Quelle:2024
Band/Heft Quelle:280(2024), 6 vom: Dez., Seite 986-99
ISSN Quelle:1528-1140
Abstract:Objective: To define the role of adjuvant therapy in duodenal adenocarcinoma (DAC) and intestinal subtype ampullary carcinoma (iAC). - Background: DAC and iAC share a similar histologic differentiation but the benefit of adjuvant therapy remains unclear. Methods: Patients undergoing curative intent surgical resection for DAC and iAC between 2010 and 2021 at 5 high-volume centers were included. Patient baseline, perioperative, and long-term oncological outcomes were evaluated. Statistical testing was performed with SPSS 25 (IBM). Results: A total of 136 patients with DAC and 171 with iAC were identified. Patients with DAC had more advanced tumors than those with iAC. Median overall survival (OS) in patients with DAC was 101 months versus 155 months for patients with iAC (P = 0.098). DAC had a higher rate of local (14.1% vs 1.2%, P < 0.001) and systemic recurrence (30.4% vs 3.5%, P < 0.001). Adjuvant therapy failed to improve OS in all patients with DAC and iAC. For DAC, patients with perineural invasion, but not other negative prognostic factors, had improved OS rates with adjuvant therapy (72 vs 44 m, P = 0.044). Patients with iAC with N+ (190 vs 57 m, P = 0.003), T3-T4 (177 vs 59 m, P = 0.050), and perineural invasion (150 vs 59 m, P = 0.019) had improved OS rates with adjuvant therapy. Conclusions: While adjuvant therapy fails to improve OS in all patients with DAC and iAC in the current study, it improved OS in patients with DAC with perineural invasion and in patients with iAC with T3-T4 tumors, positive lymph nodes, and perineural invasion.
DOI:doi:10.1097/SLA.0000000000006129
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1097/SLA.0000000000006129
 Volltext: http://journals.lww.com/annalsofsurgery/fulltext/2024/12000/the_role_of_adjuvant_therapy_in_duodenal.16.aspx
 DOI: https://doi.org/10.1097/SLA.0000000000006129
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1921785926
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69329030   QR-Code
zum Seitenanfang